Cargando…

Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970492/
https://www.ncbi.nlm.nih.gov/pubmed/35358293
http://dx.doi.org/10.1371/journal.pone.0266498
_version_ 1784679468117262336
collection PubMed
description
format Online
Article
Text
id pubmed-8970492
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89704922022-04-01 Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation PLoS One Expression of Concern Public Library of Science 2022-03-31 /pmc/articles/PMC8970492/ /pubmed/35358293 http://dx.doi.org/10.1371/journal.pone.0266498 Text en © 2022 The PLOS ONE Editors https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Expression of Concern
Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title_full Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title_fullStr Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title_full_unstemmed Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title_short Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
title_sort expression of concern: interferon and ribavirin combination treatment synergistically inhibit hcv internal ribosome entry site mediated translation at the level of polyribosome formation
topic Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970492/
https://www.ncbi.nlm.nih.gov/pubmed/35358293
http://dx.doi.org/10.1371/journal.pone.0266498
work_keys_str_mv AT expressionofconcerninterferonandribavirincombinationtreatmentsynergisticallyinhibithcvinternalribosomeentrysitemediatedtranslationatthelevelofpolyribosomeformation